ACRUX Ltd Total Assets

Latest as of June 2025: AU$7.22 Million AUD ≈ $5.11 Million USD

ACRUX Ltd total assets. Based on the latest financial reports, ACRUX Ltd (ACR) holds total assets worth AU$7.22 Million AUD (≈ $5.11 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market cap of ACRUX Ltd for the company's overall valuation and market capitalisation.

Total Assets of ACRUX Ltd (2001–2025)

Total assets of ACRUX Ltd from 2001 to 2025. This chart illustrates how ACRUX Ltd's total assets have evolved over time, based on quarterly financial data. See ACR share price today for real-time trading data and today's change.

ACRUX Ltd - Asset Composition Analysis

ACRUX Ltd Total Assets Breakdown (June 2025)

ACRUX Ltd total assets breakdown as of June 2025. ACRUX Ltd's total assets of AU$7.22 Million consist of 66.5% current assets and 33.5% non-current assets.

Asset Category Amount (AUD) % of Total Assets
Cash & Equivalents AU$0.00 11.9%
Accounts Receivable AU$3.79 Million 52.5%
Inventory AU$0.00 0.0%
Property, Plant & Equipment AU$1.86 Million 25.7%
Intangible Assets AU$0.00 0.0%
Goodwill AU$0.00 0.0%

Asset Composition Trend (2001–2025)

This chart illustrates how ACRUX Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore ACR working capital efficiency to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: ACRUX Ltd's current assets represent 66.5% of total assets in 2025, an increase from 0.0% in 2001.
  • Cash Position: Cash and equivalents constituted 11.9% of total assets in 2025, down from 96.4% in 2001.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2001.
  • Asset Diversification: The largest asset category is accounts receivable at 52.5% of total assets.

ACRUX Ltd Competitors by Total Assets

Key competitors of ACRUX Ltd based on total assets are shown below.

Company Country Total Assets
Samsung Biologics Co Ltd
KO:207940
Korea ₩12.65 Trillion
Abivax SA
PA:ABVX
France €547.14 Million
Tubize-Fin
BR:TUB
Belgium €1.99 Billion
BB Biotech AG
SW:BION
Switzerland CHF3.09 Billion
Sinocelltech Group Ltd
SHG:688520
China CN¥3.76 Billion
Inner Mongolia Furui Med Sci
SHE:300049
China CN¥3.47 Billion
Mineralys Therapeutics, Inc. Common Stock
NASDAQ:MLYS
USA $667.85 Million
GH Research PLC
NASDAQ:GHRS
USA $372.35 Million

ACRUX Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.07 1.61 4.63
Quick Ratio 1.07 1.57 4.63
Cash Ratio 0.19 0.79 3.45
Working Capital AU$323.00K AU$2.26 Million AU$9.68 Million

ACRUX Ltd - Advanced Valuation Insights

This section examines the relationship between ACRUX Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 5.62
Latest Market Cap to Assets Ratio 0.40
Asset Growth Rate (YoY) -19.4%
Total Assets AU$7.22 Million
Market Capitalization $2.91 Million USD

Valuation Analysis

Below Book Valuation: The market values ACRUX Ltd's assets below their book value (0.40x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: ACRUX Ltd's assets decreased by 19.4% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for ACRUX Ltd (2001–2025)

The table below shows the annual total assets of ACRUX Ltd from 2001 to 2025.

Year Total Assets Change
2025-06-30 AU$7.22 Million
≈ $5.11 Million
-19.39%
2024-06-30 AU$8.96 Million
≈ $6.34 Million
-37.32%
2023-06-30 AU$14.30 Million
≈ $10.12 Million
-6.38%
2022-06-30 AU$15.27 Million
≈ $10.81 Million
-36.89%
2021-06-30 AU$24.20 Million
≈ $17.12 Million
+30.67%
2020-06-30 AU$18.52 Million
≈ $13.10 Million
-24.20%
2019-06-30 AU$24.43 Million
≈ $17.29 Million
-24.80%
2018-06-30 AU$32.49 Million
≈ $22.99 Million
-31.32%
2017-06-30 AU$47.31 Million
≈ $33.47 Million
-11.36%
2016-06-30 AU$53.37 Million
≈ $37.76 Million
+10.05%
2015-06-30 AU$48.49 Million
≈ $34.31 Million
-8.88%
2014-06-30 AU$53.22 Million
≈ $37.66 Million
+0.62%
2013-06-30 AU$52.90 Million
≈ $37.43 Million
-9.58%
2012-06-30 AU$58.50 Million
≈ $41.39 Million
-0.84%
2011-06-30 AU$58.99 Million
≈ $41.74 Million
-29.44%
2010-06-30 AU$83.61 Million
≈ $59.16 Million
+139.21%
2009-06-30 AU$34.95 Million
≈ $24.73 Million
-15.31%
2008-06-30 AU$41.27 Million
≈ $29.20 Million
+102.60%
2007-06-30 AU$20.37 Million
≈ $14.41 Million
-12.33%
2006-06-30 AU$23.23 Million
≈ $16.44 Million
-25.28%
2005-06-30 AU$31.09 Million
≈ $22.00 Million
+218.66%
2004-06-30 AU$9.76 Million
≈ $6.90 Million
-24.04%
2003-06-30 AU$12.85 Million
≈ $9.09 Million
-30.02%
2002-06-30 AU$18.36 Million
≈ $12.99 Million
+52.72%
2001-06-30 AU$12.02 Million
≈ $8.50 Million
--

About ACRUX Ltd

AU:ACR Australia Biotechnology
Market Cap
$2.91 Million
AU$4.11 Million AUD
Market Cap Rank
#29487 Global
#1649 in Australia
Share Price
AU$0.01
Change (1 day)
+0.00%
52-Week Range
AU$0.01 - AU$0.02
All Time High
AU$0.83
About

Acrux Limited, together with its subsidiaries, develops and commercializes generic and topically applied pharmaceutical products in Australia, Europe, the United States, and internationally. The company provides estradiol transdermal sprays to women for the treatment of flushes associated with menopause under the Evamist and Lenzetto brand names; Dapsone 5% and Dapsone 7.5%, which are gels for th… Read more